BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25876786)

  • 1. [Successful treatment with rituximab and romiplostim for thrombocytopenia associated with Waldenström's macroglobulinemia initially presenting as Evans syndrome].
    Nozaki Y; Koshiishi M; Sueki Y; Kawashima I; Yamamoto T; Nakajima K; Mitsumori T; Kirito K
    Rinsho Ketsueki; 2015 Mar; 56(3):317-22. PubMed ID: 25876786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of romiplostim in the treatment of severe thrombocytopenia associated to Evans syndrome refractory to rituximab.
    Gonzalez-Nieto JA; Martin-Suarez I; Quattrino S; Ortiz-Lopez E; Muñoz-Beamud FR; Colchero-Fernández J; Alcoucer-Diaz MR
    Lupus; 2011 Oct; 20(12):1321-3. PubMed ID: 21719526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab.
    Ruiz-Arguelles GJ; Ruiz-Delgado GJ; Velázquez-Sánchez-de-Cima S; Zamora-Ortiz G
    Hematology; 2013 May; 18(3):175-7. PubMed ID: 23321502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of severe newly diagnosed immune thrombocytopenia involving an alveolar hemorrhage with combination therapy consisting of romiplostim, rituximab and vincristine.
    Okazuka K; Masuko M; Matsuo Y; Miyakoshi S; Tanaka T; Kozakai T; Kobayashi H; Fuse K; Shibasaki Y; Moriyama M; Takizawa J; Fuse I; Toba K; Furukawa T
    Intern Med; 2013; 52(11):1239-42. PubMed ID: 23728563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of the thermal amplitude after rituximab treatment for cold agglutinin disease with Waldenström's macroglobulinemia.
    Hattori N; Ishii N; Ariizumi H; Adachi D; Matsuda I; Nakamaki T; Tomoyasu S
    Ann Hematol; 2010 Jan; 89(1):103-4. PubMed ID: 19513714
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy.
    Mitsuhashi K; Ishiyama M; Imai Y; Shiseki M; Mori N; Teramura M; Seshimo A; Motoji T
    Br J Haematol; 2012 Sep; 158(6):798-800. PubMed ID: 22758388
    [No Abstract]   [Full Text] [Related]  

  • 7. [Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP].
    Mori M; Kato M; Koh K; Hanada R
    Rinsho Ketsueki; 2015 May; 56(5):511-3. PubMed ID: 26062675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progression of bone marrow fibrosis with reticulin and collagen hyperplasia during treatment with the thrombopoietin receptor agonist romiplostim in a patient with immune thrombocytopenia].
    Kirito K; Komatsu N
    Rinsho Ketsueki; 2013 Mar; 54(3):295-9. PubMed ID: 23676646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus.
    Alkaabi JK; Alkindi S; Riyami NA; Zia F; Balla LM; Balla SM
    Lupus; 2012 Dec; 21(14):1571-4. PubMed ID: 23161577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Romiplostim for the management of perioperative thrombocytopenia.
    Al-Samkari H; Marshall AL; Goodarzi K; Kuter DJ
    Br J Haematol; 2018 Jul; 182(1):106-113. PubMed ID: 29767837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.
    Newland A; Godeau B; Priego V; Viallard JF; López Fernández MF; Orejudos A; Eisen M
    Br J Haematol; 2016 Jan; 172(2):262-73. PubMed ID: 26537623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of romiplostim in a hemodialysis patient with primary immune thrombocytopenia.
    Al-Jafar H; Giagounidis A; El-Rashaid K; Al-Ali M; Hakim AA
    Ann Pharmacother; 2012 Nov; 46(11):e31. PubMed ID: 23115229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG-associated immune thrombocytopenia in Waldenström macroglobulinemia.
    Nakazaki K; Hangaishi A; Nakamura F; Hosoi M; Imai Y; Takahashi T; Nannya Y; Kurokawa M
    Int J Hematol; 2010 Sep; 92(2):360-3. PubMed ID: 20658219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evans syndrome after unrelated bone marrow transplantation for refractory cytopenia of childhood.
    Ueki H; Igarashi S; Kimura S; Tsuchimochi T; Furudate K; Sakurai A; Noguchi Y; Sunami S
    Pediatr Transplant; 2014 Nov; 18(7):E246-51. PubMed ID: 25074497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations.
    Aoki T; Harada Y; Matsubara E; Suzuki T; Oyama T; Kasai M; Uchida T; Ogura M
    J Clin Pharm Ther; 2012 Dec; 37(6):729-32. PubMed ID: 22583038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single center experience with romiplostim for the management of chemotherapy-induced thrombocytopenia.
    Miao J; Leblebjian H; Scullion B; Parnes A
    Am J Hematol; 2018 Aug; 93(4):E86-E88. PubMed ID: 29274130
    [No Abstract]   [Full Text] [Related]  

  • 17. Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care.
    Kuter DJ; Mathias SD; Rummel M; Mandanas R; Giagounidis AA; Wang X; Deuson RR
    Am J Hematol; 2012 May; 87(5):558-61. PubMed ID: 22460421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of post-transplant thrombocytopenia with romiplostim in a pediatric patient with X-linked chronic granulomatous disease.
    Buchbinder D; Hsieh L; Krance R; Nugent DJ
    Pediatr Transplant; 2014 Nov; 18(7):E252-4. PubMed ID: 25118016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Romiplostim treatment allows for platelet transfusion-free liver transplantation in pediatric thrombocytopenic patient with primary sclerosing cholangitis.
    Minowa K; Arai K; Kasahara M; Sakamoto S; Shimizu H; Nakano N; Ito R; Obayashi N; Nakazawa A; Ishiguro A
    Pediatr Transplant; 2014 Sep; 18(6):E212-5. PubMed ID: 25041553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Romiplostim resistance in secondary failure of platelet recovery.
    DeRemer DL; Katsanevas K; Bradley A; Awan FT
    J Oncol Pharm Pract; 2013 Dec; 19(4):369-72. PubMed ID: 23292974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.